Global healthcare discount plan industry through 2026

Dublin, September 06, 2021 (GLOBE NEWSWIRE) – The report “Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunities, and Forecasts 2021-2026” was added to to offer.

The global medical cannabis market experienced strong growth in the period 2015-2020. Cannabis is a psychoactive drug derived from the cannabis plant of the Cannabaceae family. It was used medicinally in ancient Indian, Chinese, Egyptian, and Islamic cultures. Nowadays, cannabis is used in the treatment of a wide variety of diseases and symptoms, including cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, multiple sclerosis, acquired immunodeficiency syndrome (AIDS), amyotrophic lateral sclerosis (ALS.). ), Alzheimer’s, Post Traumatic Stress Disorder (PTSD), Parkinson’s, and Tourette. Because of its therapeutic benefits, cannabis is approved for medical use in numerous countries with varying legal restrictions. Some of these countries are Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Germany, Italy, Mexico, Spain, the United Kingdom, the United States, and Uruguay. Looking ahead, the publisher expects the global medical cannabis market to grow at a CAGR of 15.3% in the period 2021-2026.

Cannabis is safer and has fewer serious side effects compared to other treatment options. It is also used in conjunction with other treatments, either to improve their effectiveness or to combat adverse side effects. For example, it is very effective in reducing nausea and increasing appetite in chemotherapy patients. It is also used in combination with conventional opioid pain relievers, which allows patients to significantly reduce the dosage and frequency of opioids and achieve greater pain relief.

The steadily aging population around the world has played a significant role in increasing the demand for medical cannabis as geriatric patients are more likely to develop chronic diseases and require more doctor visits.

Clinical studies, research and development activities (R&D) and the commercialization of cannabis-based indications are expected to further accelerate market growth.

Although spending on health products is less prone to fluctuations, medical marijuana use is subject to changes in disposable income due to its unconventional nature. As a result, rising disposable incomes are predicted to have a positive impact on the demand for medical cannabis.

Key market segmentation:

The story goes on

The editor offers an analysis of the key trends in each sub-segment of the global Medical Cannabis Market report, along with growth forecast at the global, regional and country level from 2021-2026. Our report has categorized the market by region, species, derivatives, application, end use, and route of administration.

Distribution according to types:

Based on the species, the market has been divided into Cannabis Indica, Sativa and Hybrid. Currently, cannabis indica is dominating the market and holding the largest share. It is widely used to treat insomnia, relax muscles, relieve body pain, headaches, and migraines.

Splitting through derivatives:

Based on derivatives, the market has been divided into cannabidiol (CBD), tetrahydrocannabinol (THC) and others. CBD is mainly used for medicinal purposes due to its non-psychotic effects and low toxicity, while THC is used to reduce the side effects of AIDS and cancer treatment.

Distribution according to application:

The market was also divided by application; with cancer being the leading category. Other main uses of cannabis are arthritis, migraines, epilepsy, and others.

Breakdown by end use:

On the basis of end use, the market has been divided into pharmaceutical industry, research and development centers, and others. The pharmaceutical industry is currently the largest end user.

Division by route of administration:

Based on the route of administration, the market has been divided into oral solutions and capsule, smoking, vaporizer, topical, and others. Oral solutions and capsules represent the largest segment with the largest market share.

Regional insights:

On the geographic front, North America (USA and Canada) occupies the leading position in the market. The recent legalization of cannabis in North America for both recreational and medicinal uses has been a major driver of market growth. Other key regions are Europe (Germany, Italy, France, the Netherlands and Spain), Asia-Pacific, Latin America and the Middle East and Africa.

Mentioned companies

  • Canopy Growth Corporation

  • GW Pharma

  • Aurora Cannabis Inc

  • Aphria Inc.

  • MedReleaf Corporation

  • Insys Therapeutics Inc

  • CanniMed Therapeutics Inc

  • Cara Therapeutics Inc

  • United Cannabis Corporation

Key questions answered in this report:1. How big is the market for the global medical cannabis market?
2. How is the global medical cannabis market growing?
3. What are the global medical cannabis market drivers?
4. What are the major industry trends in the global medical cannabis market?
5. What is the impact of COVID-19 on the global medical cannabis market?
6. How is the global medical cannabis market split by species?
7. How is the global medical cannabis market divided by derivatives?
8. What is the breakdown of the global medical cannabis market by application?
9. What is the breakdown of the global medical cannabis market based on end-use?
10. How is the global medical cannabis market broken down by route of administration?
11. What are the major regions in the global medical cannabis market?
12. Who are the key companies / players in the global medical cannabis market?

Key topics covered:

1 Introduction

2 Scope and methodology

3 Summary

4 Introduction
4.1 Overview
4.2 Major industry trends

5 Global Medical Cannabis Market
5.1 Market overview
5.2 Market performance
5.3 Effects of COVID-19
5.4 Market division by type
5.5 Market allocation by derivatives
5.6 Market division by application
5.7 Market division according to end consumer
5.8 Market division by administrative route
5.9 Market breakdown by region
5.10 Market forecast
5.11 SWOT analysis
5.11.1 Overview
5.11.2 Strengths
5.11.3 weaknesses
5.11.4 Opportunities
5.11.5 Threats
5.12 Value chain analysis
5.12.1 Input suppliers
5.12.2 Collectors
5.12.3 Manufacturer
5.12.4 Distribution partners
5.12.5 Exporters
5.12.6 Dealer
5.12.7 End Users
5.13 Five Forces Analysis of Beams
5.13.1 Overview
5.13.2 Bargaining power of buyers
5.13.3 Bargaining power of suppliers
5.13.4 Degree of competition
5.13.5 Threat from new entrants
5.13.6 Proxy threat
5.14 Key Success and Risk Factors

6 Market division by type
6.1 Indicates
6.1.1 Market trends
6.1.2 Market forecast
6.2 Sativa
6.2.1 Market trends
6.2.2 Market forecast
6.3 hybrid
6.3.1 Market trends
6.3.2 Market forecast

7 Market allocation by derivatives
7.1 Cannabidiol (CBD)
7.1.1 Market trends
7.1.2 Market forecast
7.2 Tetrahydrocannabinol (THC)
7.2.1 Market trends
7.2.2 Market forecast
7.3 Other
7.3.1 Market trends
7.3.2 Market forecast

8 Market division by application
8.1 Cancer
8.1.1 Market trends
8.1.2 Market forecast
8.2 Arthritis
8.2.1 Market trends
8.2.2 Market forecast
8.3 Migraines
8.3.1 Market trends
8.3.2 Market forecast
8.4 epilepsy
8.4.1 Market trends
8.4.2 Market forecast
8.5 Other
8.5.1 Market trends
8.5.2 Market forecast

9 Market division according to end consumer
9.1 Pharmaceutical industry
9.1.1 Market trends
9.1.2 Market forecast
9.2 Research and Development Centers
9.2.1 Market trends
9.2.2 Market forecast
9.3 Other
9.3.1 Market trends
9.3.2 Market forecast

10 Market division by administrative route
10.1 Oral solutions and capsules
10.1.1 Market trends
10.1.2 Market forecast
10.2 smoking
10.2.1 Market Trends
10.2.2 Market forecast
10.3 evaporator
10.3.1 Market Trends
10.3.2 Market forecast
10.4 Topics
10.4.1 Market Trends
10.4.2 Market forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market forecast

11 Market breakdown by region

12 Overview of clinical research suggesting the benefits of medicinal cannabis in various indications
12.1 Alzheimer’s Disease
12.2 Autism
12.3 Cancer
12.4 Chronic pain
12.5 epilepsy
12.6 Migraines
12.7 Indigestion
12.8 Multiple Sclerosis
12.9 Schizophrenia
12.10 Other

13 Competitive Landscape
13.1 Market structure
13.2 Key Players

14 important player profiles

Please visit for more information on this report

CONTACT: CONTACT: Laura Wood, Senior Press Manager [email protected] For EST office hours, call 1-917-300-0470 at 353-1-416-8900